58 related articles for article (PubMed ID: 9842987)
1. Role of sex hormones in the modulation of cholangiocyte function.
Mancinelli R; Onori P; Demorrow S; Francis H; Glaser S; Franchitto A; Carpino G; Alpini G; Gaudio E
World J Gastrointest Pathophysiol; 2010 Jun; 1(2):50-62. PubMed ID: 21607142
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogen therapy: uncertainties and risk assessment.
Smith LL; White IN
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):14-22. PubMed ID: 9556786
[TBL] [Abstract][Full Text] [Related]
3. Understanding the genotoxicity of tamoxifen?
Phillips DH
Carcinogenesis; 2001 Jun; 22(6):839-49. PubMed ID: 11375888
[TBL] [Abstract][Full Text] [Related]
4. Species differences in the metabolic activation of tamoxifen into genotoxic derivatives: risk assessment in women.
De Matteis F; White IN; Smith LL
Eur J Drug Metab Pharmacokinet; 1998; 23(3):425-8. PubMed ID: 9842987
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation of tamoxifen by recombinant human cytochrome p450 enzymes.
Notley LM; De Wolf CJ; Wunsch RM; Lancaster RG; Gillam EM
Chem Res Toxicol; 2002 May; 15(5):614-22. PubMed ID: 12018981
[TBL] [Abstract][Full Text] [Related]
6. DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives.
Gamboa da Costa G; McDaniel-Hamilton LP; Heflich RH; Marques MM; Beland FA
Carcinogenesis; 2001 Aug; 22(8):1307-15. PubMed ID: 11470763
[TBL] [Abstract][Full Text] [Related]
7. Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen.
Osborne MR; Hewer A; Hardcastle IR; Carmichael PL; Phillips DH
Cancer Res; 1996 Jan; 56(1):66-71. PubMed ID: 8548777
[TBL] [Abstract][Full Text] [Related]
8. Identification of tamoxifen-DNA adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen.
Dasaradhi L; Shibutani S
Chem Res Toxicol; 1997 Feb; 10(2):189-96. PubMed ID: 9049430
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients.
Hemminki K; Rajaniemi H; Lindahl B; Moberger B
Cancer Res; 1996 Oct; 56(19):4374-7. PubMed ID: 8813128
[TBL] [Abstract][Full Text] [Related]
10. Effect of tamoxifen feeding on metabolic activation of tamoxifen by the liver of the rhesus monkey: does liver accumulation of inhibitory metabolites protect from tamoxifen-dependent genotoxicity and cancer?
Comoglio A; Gibbs AH; White IN; Gant T; Martin EA; Smith LL; Gamalero SR; DeMatteis F
Carcinogenesis; 1996 Aug; 17(8):1687-93. PubMed ID: 8761427
[TBL] [Abstract][Full Text] [Related]
11. Lack of genotoxicity of tamoxifen in human endometrium.
Carmichael PL; Ugwumadu AH; Neven P; Hewer AJ; Poon GK; Phillips DH
Cancer Res; 1996 Apr; 56(7):1475-9. PubMed ID: 8603387
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo.
Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K
Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen induces hepatocellular carcinoma in rat liver: a 1-year study with two antiestrogens.
Hirsimäki P; Hirsimäki Y; Nieminen L; Payne BJ
Arch Toxicol; 1993; 67(1):49-54. PubMed ID: 8452480
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
